Listen for Gliptin Patients Complaining of Severe Joint Pain

New warnings from experts will spur questions about whether gliptins (Januvia, Onglyza, etc) cause severe joint pain.

This risk seems to be a class effect of gliptins, and it's very rare...but the pain can be disabling.

We know these diabetes meds inhibit dipeptidyl peptidase-4 (DPP-4) enzyme that breaks down incretin hormones.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote